tradingkey.logo
tradingkey.logo
Search

Sotera Health Co

SHC
Add to Watchlist
17.860USD
+0.010+0.06%
Close 07-31 16:00ETQuotes delayed by 15 min
5.07BMarket Cap
43.08P/E TTM

More Details of Sotera Health Co Company

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Sotera Health Co Info

Ticker SymbolSHC
Company nameSotera Health Co
IPO dateNov 20, 2020
CEOPetras (Michael B)
Number of employees3000
Security typeOrdinary Share
Fiscal year-endNov 20
Address9100 South Hills Blvd, Suite 300
CityBROADVIEW HEIGHTS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code44147
Phone14402621410
Websitehttps://soterahealth.com/
Ticker SymbolSHC
IPO dateNov 20, 2020
CEOPetras (Michael B)

Company Executives of Sotera Health Co

Name
Name/Position
Position
Shareholding
Change
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
140.93K
+10.62%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
95.75K
+15.63%
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
95.75K
+15.63%
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
87.30K
+84.29%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
54.19K
+27.62%
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--
Mr. Constantine S. (Dean) Mihas
Mr. Constantine S. (Dean) Mihas
Independent Director
Independent Director
--
--
Dr. David E. Wheadon, M.D.
Dr. David E. Wheadon, M.D.
Independent Director
Independent Director
--
--
Mr. Sean L. Cunningham
Mr. Sean L. Cunningham
Independent Director
Independent Director
--
--
Mr. Michael B. Petras, Jr.
Mr. Michael B. Petras, Jr.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
140.93K
+10.62%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
95.75K
+15.63%
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
95.75K
+15.63%
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
87.30K
+84.29%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
54.19K
+27.62%
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Sotera Health Co?

The top five shareholders of Sotera Health Co are: Ms. Ann R. Klee

How many institutions hold shares of Sotera Health Co (SHC)?

As of 2026Q1, 534 institutions hold shares of Sotera Health Co, with a combined market value of approximately 269.76M, accounting for 94.60% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 20759750.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.